Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Lee430on Apr 18, 2024 9:03am
113 Views
Post# 35995525

RE:RE:RE:RE:RE:RE:RE:RE:RE:I don't know what it takes

RE:RE:RE:RE:RE:RE:RE:RE:RE:I don't know what it takesGotta admit that Thera’s management doesn’t exactly have a reputation for being forthright, one might even say deceptive or go as far as saying all out lying, if I recall they said one time that NO NO were not doing a financing then a few of days later they did a spectacularly stupid capital raise.

palinc2000 wrote:

I dont believe for one minute that they found him on their own.
Soleus and THTX would have needed to disclose their agreement with Soleus if Zwick had been Nominated in accordance to a formal agreement between the parties...
Thus instead of making waves Thtx agreed to a "suggestion"  or "reccommendatiom"from Soleus about a nomination of a Board Member upon a vacancy ..
I would not be surprised if the replacement  of the Chairwoman was also the result of a "recommendation by Soleus
As I recall you and others tried (without success) to do what I think Soleus did
If you had been successful I dont think Thtx would have avknowledged this publicly

 


SPCEO1 wrote: Someone I know asked the company if Soleus nominated him and was told that THTX found him on their own. So, it is second hand info, but reliable info if THTX is telling the truth (in other words, my source is almost certainly accurately reporting what THTX told him).

Also, Soleus did file with the SEC as an activist shareholder indicating a potential interest in influencing the company through their activism. Now, I will believe Soleus would actually act in an activist manner when I see it since they invest in a lot of small companies and likely do not want a reputation as an activist investor. There is nothing in the public arena which suggests they have taken any action yet which comports with their potential activism.

So, my best guess is they vote in favor of management at the AGM, even if they are not happy with them (and how could they be happy with them as they have suffered similar losses as the rest of us). It is just not typical for institutional investors to vote against management unless their fund was expressly organized for that purpose.

Still, Soleus did file to be an activist with the SEC, so there is clearly some chance they may be looking to do something. I believe someone here pointed out that the new large shareholder might be friends of Soleus and may have had a more activist approach? So, maybe something is up, but as I said, I will beleive it whenI see it. And if they are planning on doing something at the AGM, they need to reveal themselves as having such intentions very soon.
palinc2000 wrote:

Why do you have that impression?

Soleus is not known as an Activist shareholder and this is probably the reason that Zwick 's nomination was not announced as a Soleus nominee even though I think he was nominated as a result of discussions between Thtx and Soleus...and Soleus may have signed an NDA 


 


SPCEO1 wrote: I am under the impression Zwick was not recommended by Soleus.
Trogarzon wrote: Hope they fly out the door... all of them except Zwick.  Then Soleus can monetise.



 




 



<< Previous
Bullboard Posts
Next >>